159 related articles for article (PubMed ID: 16055291)
1. Effects of Byakko-ka-ninjin-to on salivary secretion and bladder function in rats.
Sakaguchi M; Goto K; Ichiki H; Hattori N; Iizuka A; Yamamoto M; Takeda S; Ishige A; Aburada M; Yasuda M; Yamamoto T
J Ethnopharmacol; 2005 Nov; 102(2):164-9. PubMed ID: 16055291
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of percutaneous and intraduodenal administration of oxybutynin on bladder contraction and salivation in rabbits.
Kontani H; Hamamoto T; Takeuchi S; Nomura Y; Sawanishi H; Saito H
Int J Urol; 2006 Jul; 13(7):977-84. PubMed ID: 16882066
[TBL] [Abstract][Full Text] [Related]
3. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs.
Noronha-Blob L; Kachur JF
J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
[TBL] [Abstract][Full Text] [Related]
5. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
[TBL] [Abstract][Full Text] [Related]
6. [Effects of propiverine hydrochloride (propiverine) on the muscarinic receptor binding affinity in guinea pig tissues and on salivation in conscious dogs].
Nagao M; Kaneko S; Hirota T; Isogai M; Shimizu H
Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):157-66. PubMed ID: 10347840
[TBL] [Abstract][Full Text] [Related]
7. Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion.
Oki T; Toma-Okura A; Yamada S
J Pharmacol Exp Ther; 2006 Mar; 316(3):1137-45. PubMed ID: 16282521
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Oki T; Sato S; Miyata K; Yamada S
Br J Pharmacol; 2005 May; 145(2):219-27. PubMed ID: 15753946
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Naruganahalli KS; Sinha S; Hegde LG; Meru AV; Chugh A; Kumar N; Gupta JB; Ray A
Eur J Pharmacol; 2007 Oct; 572(2-3):207-12. PubMed ID: 17610864
[TBL] [Abstract][Full Text] [Related]
10. Combined potentiating effect of byakko-ka-ninjin-to, its constituents, rhizomes of Anemarrhena asphodeloides, tomosaponin A-III, and calcium on pilocarpine-induced saliva secretion in streptozocin-diabetic mice.
Kimura M; Kimura I; Chem FJ
Biol Pharm Bull; 1996 Jul; 19(7):926-31. PubMed ID: 9004927
[TBL] [Abstract][Full Text] [Related]
11. A standardised mini pig model for in vivo investigations of anticholinergic effects on bladder function and salivation.
Scheepe JR; van den Hoek J; Jünemann KP; Alken P
Pharmacol Res; 2007 May; 55(5):450-4. PubMed ID: 17368042
[TBL] [Abstract][Full Text] [Related]
12. In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
Oki T; Kawashima A; Uchida M; Yamada S
Life Sci; 2005 Apr; 76(21):2445-56. PubMed ID: 15763076
[TBL] [Abstract][Full Text] [Related]
13. Influence of estradiol pretreatment on antimuscarinic action of oxybutynin in rat detrusor muscle.
Yildiz O; Ozgok Y; Seyrek M; Un I; Kilciler M; Tuncer M
Urology; 2005 Apr; 65(4):800-3. PubMed ID: 15833550
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of the effects of propiverine, terodiline, oxybutynin on the lower urinary tract function in the decerebrate dog].
Tsuchida S; Nishizawa O; Noto H; Kaneko S
Hinyokika Kiyo; 1990 Aug; 36(8):915-9. PubMed ID: 2239592
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: inhibition of antimuscarinics on bladder afferents in conscious rats.
Haga N; Aikawa K; Shishido K; Takahashi N; Yanagida T; Yamaguchi O
Urology; 2009 Jan; 73(1):200-4. PubMed ID: 18561989
[TBL] [Abstract][Full Text] [Related]
16. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).
Fox PC; Atkinson JC; Macynski AA; Wolff A; Kung DS; Valdez IH; Jackson W; Delapenha RA; Shiroky J; Baum BJ
Arch Intern Med; 1991 Jun; 151(6):1149-52. PubMed ID: 2043017
[TBL] [Abstract][Full Text] [Related]
17. Salivation triggered by pilocarpine involves aquaporin-5 in normal rats but not in irradiated rats.
Asari T; Maruyama K; Kusama H
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):531-8. PubMed ID: 19673936
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
[TBL] [Abstract][Full Text] [Related]
19. Effects of propiverine and its metabolite propiverine-N-oxide on bladder contraction and salivation in mini pigs.
Scheepe JR; Braun PM; Jünemann KP; Alken P
Urol Int; 2008; 81(4):468-73. PubMed ID: 19077412
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
